van Tilburg, Cornelis Milde, Till Witt, Ruth Ecker, Jonas Hielscher, Thomas Seitz, Angelika Schenk, Jens-Peter Buhl, Juliane Riehl, Dennis Frühwald, Michael Pekrun, Arnulf Rossig, Claudia Wieland, Regina Flotho, Christian Kordes, Uwe Gruhn, Bernd Simon, Thorsten Linderkamp, Christin Sahm, Felix Taylor, Lenka Freitag, Angelika Burhenne, Jürgen Foerster, Kathrin Meid, Andreas Pfister, Stefan Karapanagiotou-Schenkel, Irini Witt, Olaf MOESM1 of Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia Additional file 1: Figure S1. a Linear correlation Cmax (ng/mL) – Dose (mg/m2/d). b Concentration of vorinostat in plasma according to dose level. Vorinostat;Intra-patient dose escalation;Dose-response;Cytokine;Child;HDAC 2019-12-11
    https://springernature.figshare.com/articles/presentation/MOESM1_of_Phase_I_II_intra-patient_dose_escalation_study_of_vorinostat_in_children_with_relapsed_solid_tumor_lymphoma_or_leukemia/11352689
10.6084/m9.figshare.11352689.v1